← FDA Drug Approvals (Drugs@FDA)

PREVYMIS

NDA · New Drug Application · Sponsor: MSD · Approved 2024-08-30

Drug application

FDA Application #

NDA219104

Application type

New Drug Application

Brand name

PREVYMIS

Generic name

LETERMOVIR

Active ingredients

LETERMOVIR

Dosage form

PELLETS

Route

ORAL

Marketing status

Prescription

Sponsor

MSD

Manufacturer

Merck Sharp & Dohme LLC

First approval

2024-08-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown